Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Bonaventura Clotet, MD, PhD
Woman and Man Max 99 years
Bonaventura Clotet, MD, PhD
Update Il y a 4 ans
Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients
This is a study on the utility of the modification of doses of efavirenz guided by its plasma concentration (therapeutic drug monitoring) in HIV-infected patients initiating treatment with...
Country
Spain
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bonaventura Clotet, MD, PhD
Update Il y a 4 ans
Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
The purpose of this study is to characterise the pharmacokinetic profiles of non-nucleoside analog reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs), and the influenc...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bonaventura Clotet, MD, PhD
Update Il y a 4 ans
Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily
To evaluate the proportion of patients with virological failure after 48 weeks of treatment with the combination of efavirenz 600 mg + lamivudine (3TC) 300 mg + abacavir 600 mg once daily ...
Country
Spain
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bonaventura Clotet, MD, PhD
Update Il y a 4 ans
Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens
This trial will assess the sustained virologic response to treatment with peginterferon alfa-2a combined with high-dose ribavirin in human immunodeficiency virus (HIV)-infected patients wi...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bonaventura Clotet, MD, PhD
Update Il y a 4 ans
Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients
To evaluate the therapeutic equivalence between the two arms of treatment in virological and immunological response after 48 weeks and to evaluate the presence of side effects during the f...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bonaventura Clotet, MD, PhD
Update Il y a 4 ans
Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV
The purpose of this study is to compare the early virological response (EVR = undetectable [ribonucleic acid-hepatitis C virus] RNA-HCV or a reduction of > 2 log10) of patients with chroni...
Country
None
organs
None
Specialty
None
Closed trial
More information